Once-daily oral treatment for obesity that mimics metabolic effects of gastric bypass shows promise in study

A first-in-human study of an investigational once-daily oral treatment for obesity (SYNT-101) demonstrates positive preliminary data for the safe and effective redirection of nutrient absorption into the lower intestine, the weight loss and metabolic management mechanism behind gastric bypass surgery.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup